DRDima Raskolnikov

Dima Raskolnikov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dima Raskolnikov has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ureteroscopy at ambulatory surgery centers can be safe for select high-risk patients

    by Ryan Cook, Andrewe L. Baca, Alexander Small, Carina Himes, Dima Raskolnikov

    Purpose: To determine whether unhealthy patients undergoing ureteroscopy at an ambulatory surgery center are at high risk of emergency post-operative transfer to an inpatient setting. Methods: Records of 100 consecutive high-risk patients undergoing URS at a free-standing ambulatory surgery center (ASC) were reviewed. Patients were considered high-risk if their American Society of Anesthesiologists score (ASA) was ≥ 3. Perioperative risk was assessed using the Charlson Comorbidity Index (CCI) and the 5-factor Modified Frailty Index (mFI-5). Post-operative complications requiring emergent inpatient transfer on the day of surgery and complications within 30-days were recorded. Results: The median age for patients was 61.4 years (IQR: 54.7–68.4) and median BMI was 31.0 (IQR: 26.6–37.2). Common chronic illnesses were hypertension (74%), COPD (44%), diabetes (40%), and peripheral vascular disease (14%). All patients were considered high-risk by ASA score. By CCI, 28% of patients were high-risk, 23% were significant risk and 49% were mild risk, with median score of 3 (IQR 1–5). By mFI-5, 20% of patients were high-risk, with median score of 2 (IQR 1–2). No patient required emergent transfer on the day of surgery. Within 30 days postoperatively, 15 patients presented to the Emergency Department (ED) and 5 were admitted. mFI-5 and CCI were not predictive of ED visits. Conclusion: Selected high-risk patients with unfavorable ASA, mFI-5, and CCI undergoing URS within an ASC are unlikely to require emergent, post-operative transfer to an inpatient facility.


  • Reply to Editorial Comment on “Physician and Patient Adherence to Kidney Stone Prevention Guidelines in a Diverse, Low-Resource, Urban Population”

    by Emily R. Hunt, Tyler Bergeron, Beth Edelblute, Kara L. Watts, Alexander C. Small, Dima Raskolnikov

  • Open Access

    Understanding the clinical genetics of kidney stone disease using the Natera Renasight panel

    by Andrewe L. Baca, Rutul D. Patel, Kevin Labagnara, Benjamin Green, Michael Zhu, Kavita Gupta, Beth Edelblute, Andrea A. Asencio, Deep Sharma, Wei Chen, et al.

    We aimed to characterize the underlying genetics of kidney stone disease (KSD) in an urban and diverse population using the Natera Renasight genetic panel. This was a single-center prospective study of high-risk KSD patients, defined as recurrent stone formers or those with a family history with KSD. Buccal saliva DNA samples were collected with the commercially available Natera Renasight genetic panel and were analyzed using next-generation sequencing. The panel assesses 385 kidney disease related genes, including 45 linked to KSD. One hundred eleven high-risk KSD patients were enrolled. The majority were female (56%) with a median age of 50 (IQR 39.5–59.5), compromising a diverse ethnic background with 62% Hispanic, 23% White and 11% Black. Patients had median 3 (IQR 2–5) lifetime stone episodes, and 41% had family history of KSD. Genetic analysis was possible for 105 patients (95%). Eight (8%) had positive tests with only one patient found to have a pathogenic mutation associated with KSD (SLC7A9, cystinuria). The other 7 positive tests included amyloidosis (TTR, N = 3), Alport syndrome (COL4A3, N = 2), polycystic kidney disease (PKD1, N = 1), and susceptibility to ESRD (APOL1, N = 1). Patients with positive tests were more likely to have chronic kidney disease (38% vs 5%, p < 0.01), gout (13% vs 1%, p = 0.02) and carbonate apatite stones (38% vs 7%, p < 0.01). Our study sheds light on genetic factors of KSD in a diverse patient population. The results suggest that KSD is unlikely monogenetic in nature, but is more likely due to a complex interplay of polygenetic and environmental influences. Genetic testing may be most useful in KSD patients with chronic kidney disease.


  • Physician and Patient Adherence to Kidney Stone Prevention Guidelines in a Diverse, Low-resource, Urban Population

    by Emily R. Hunt, Tyler Bergeron, Beth Edelblute, Kara L Watts, Alexander C. Small, Dima Raskolnikov